DT
HealthMore in Health→
GLP-1 Heart Benefits Hold Up in Long-Term Review
Key Takeaways
- A long-term review of 11 trials linked GLP-1 drugs to lower rates of heart attack, stroke, and cardiovascular death.
- The analysis covered more than 90,000 patients and focused only on studies with at least one year of follow-up.
- Benefits were reported in high-risk patients with obesity, type 2 diabetes, or existing heart disease.
- Serious safety concerns were not meaningfully increased versus placebo, though gastrointestinal side effects remained common.
DE
DT Editorial Team··via medicalxpress.com
